Skip to main content
OpenTrials
Completed

NCT Number: NCT01548365

Impact of an Infusion Therapy Nursing Expert Service on Length of Stay and Clinical Results of Venous Access Devices

The purpose of this study is to determine whether an infusion therapy nursing expert service is effective in decreasing hospital length of stay, improving the clinical results of venous access devices and increasing patient satisfaction with venous access.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patients With Prolonged Intravenous Therapy

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Araba University Hospital

Vitoria-Gasteiz, Araba, 01009, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Require an estimated long prescription of intravenous treatment. These treatments may be of fluid therapy, pharmacological, nutritional or hemotherapy.
  • Estimation of 7 days or more of continuous intravenous therapy.
  • Estimation of an intermittent intravenous therapy of less than a week, but on a monthly basis or less and a total estimated duration superior to 3 months.
  • Be patient at Araba University Hospital

Exclusion criteria

  • To have a central venous catheter indwelled
  • MRSA (Methicillin Resistant Staphylococcus Aureus)
  • Younger than 18 years old

Treatment and study plan

Infusion therapy nursing expert service

Other

The ITNE will assess the patient and treatment characteristics and use an evidence based decision making algorithm for the selection of the most suitable VAD.

If the VAD needed is a PICC or a midline ITNE will place it following hospital's protocols. If needed, ITNE will also educate and support patients and next of keens in the maintenance of the device at home.

If other devices such as peripheral catheters, central venous catheters (jugular or subclavian) or venous subcutaneous reservoirs are the preferable VADs for patients and treatment conditions, ITNE will work together with health professionals in charge of patients to activate the usual procedures to place the according device.

Primary outcomes

  1. Hospital Length of Stay

    Time frame: 3 months

Secondary outcomes

  1. Venous Access Devices reaching end of treatment

    Time frame: 3 months

  2. Incidence of complications derived from VAD

    Time frame: 3 months

  3. Patients receiving intravenous therapy at home

    Time frame: 3 months

  4. Patient satisfaction with VAD

    Time frame: 3 months

Sponsors and collaborators

Lead sponsor

Basque Health Service

Other Gov

Collaborators

  • KRONIKGUNE Cronicity Research Centre

Registry information

Official study title

Impact of an Infusion Therapy Nursing Expert Service on Length of Stay, Clinical Results of Venous Access Devices and Satisfaction on Patients With Long Intravenous Therapy Prescription.

Acronym: ETI

Important dates

Study start
2012
Primary completion
2012
Study completion
2012
First posted
Mar 8, 2012
Registry last updated
Sep 23, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.